• Home
  • Research
  • Comparing Characteristics and Outcomes between Hospitalized Adults on a Pea Protein or Dairy/Soy Protein Formulas: Initial Findings

Comparing Characteristics and Outcomes between Hospitalized Adults on a Pea Protein or Dairy/Soy Protein Formulas: Initial Findings

Authors: Vanessa Millovich1, Irene Olsen Shingara1, Guilherme S. Lopes2, Manu Tyagi2, Zhun Cao2, and Christina J. Valentine1

Manuscript Published in Journal of Comparative Effectiveness Research

Population and Design

  • Retrospective real-world evidence study of 65,581 hospitalized adults (≥18 years) conducted using a closed U.S. claims database with total sample taken from 60 hospitals.

  • Patients consumed either organic pea protein-based formulas (n=243) or cow’s milk/soy protein-based formulas (n=65,338).

Outcomes Measured

  • Clinical characteristics, baseline risk of mortality (Charlson Comorbidity Index), GI intolerance symptoms, GI medication use, and nutritional status (malnutrition and weight loss).

  • Primary outcome for this study was length of hospital stay.

Results

  • All patients grouped into the organic pea protein-based formula group consumed Kate Farms Standard 1.4 formula.

  • Median Charlson Comorbidity Index score was higher in patients on the organic pea protein-based formula vs those on dairy/soy formulas (p<0.001).

  • Preliminary analyses showed that patients on the organic pea protein-based formula had an approximately 2-day shorter length of hospital stay than those on dairy/soy formulas (p< 0.001).

  • Similar rates of all-cause inpatient readmissions within 90 days of hospital discharge — organic pea protein-based formula = 21.4% vs dairy/soy formulas = 21.8% (p = 0.894).

  • Similar rates of all-cause outpatient medical visits within 90 days of hospital discharge — organic pea protein-based formula = 33.3% vs dairy/soy group = 29.7% (p = 0.216)

Affiliations:

1. Kate Farms, Goleta, CA, United States

2. Premier Applied Sciences, Inc., Charlotte, NC, United States

Citation:

Millovich V et al., 2026; J Comp Eff Res, 49: S164